NORTH AMERICA GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

NORTH AMERICA GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

 The North America glucose monitoring systems market reigned the global scene in 2017 for both CGMS and SMBG  markets, by capturing the highest revenue share. By the end of forecast period of 2018-2026, the CGMS market is predicted to grow by 30.19% CAGR and raise a total of $6115.5 million. On the other hand, the SMBG  market is predicted to grow by 5.34% CAGR and raise a total of $10528.1 million.

NORTH AMERICA GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

North America Continuous Glucose Monitoring System (CGMS) market by Component Type (Sensors, Transmitters & Receivers, Insulin Pump) by Application (Home Settings, Diagnostics and Clinics, Hospitals) by Component Type (Test Strips, Glucose Meter) by Application (by Application, Clinics, Hospitals) by Geography

Request free sample

The North America glucose monitoring systems market reigned the global scene in 2017 for both CGMS and SMBG  markets, by capturing the highest revenue share. By the end of forecast period of 2018-2026, the CGMS market is predicted to grow by 30.19% CAGR and raise a total of $6115.5 million. On the other hand, the SMBG  market is predicted to grow by 5.34% CAGR and raise a total of $10528.1 million.

North America glucose monitoring systems market

To learn more about this report, request a free sample copy

United States of America and Canada are the major markets for the glucose monitoring systems in the region. The U.S dominates the North America market by becoming the largest market for the sales of GMS devices. A significant growth can be seen in this region owing to the growing prevalence of obesity as well as diabetes. Also, an increased awareness among the population has augmented the sales of various GMS devices in the country. The diabetic population in the U.S and Canada has increased tremendously with time, and this further boosted the growth in CGMS as well as the SMBG market in the North American region.

Top companies in  Glucose Monitoring Systems Market include PharmaTech, LifeScan, Bayer, Abbott, Sanofi, Roche, OneTouch, Medtronic Inc., DexCom, Johnson & Johnson, Insulet Corp, Tandem Diabetes Care Inc., and Echo Therapeutics.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE STUDY MARKET
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
    • BOTTOM-UP APPROACH
    • TOP DOWN APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • CGMS MARKET IS ANTICIPATED TO BE A DEVELOPED MARKET
      • SELF-MONITORING OF BLOOD GLUCOSE HAS HUGE MARKET OPPORTUNITY
      • COLLABORATION OF SIGNIFICANT COMPANIES TO DEVELOP INTEGRATED CGMS-ENABLED INSULIN PUMPS
  1. MARKET OVERVIEW
    • DRIVERS AND IMPACT
      • RISE IN THE INCIDENCE OF DIABETES
      • INCREASE IN HEALTHCARE EXPENDITURE
      • INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
      • TECHNOLOGY INTEGRATION
      • INCREASING CGMS AND SMBG AFFORDABILITY
      • TECHNOLOGICAL ADVANCES IN GMS DEVICES
      • AWARENESS AMONG THE GENERAL POPULATION
    • RESTRAIN AND IMPACT
      • HINDERANCE FROM GOVERNMENT REGULATIONS
      • INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
      • LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
    • CHALLENGES
      • INTENSE COMPETITION AMONG VENDORS
      • INACCURACY IN READING OF GMS DEVICES
      • INCREASINGLY STRINGENT GOVERNMENT REGULATIONS
  1. CGMS MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • SENSORS
      • TRANSMITTERS AND RECEIVERS
      • INSULIN PUMP
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • DIAGNOSTICS AND CLINICS
      • HOSPITALS
  1. SMBG MARKET
  2. SMBG MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • TEST STRIPS
      • GLUCOSE METER
      • LANCETS
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • CLINICS
      • HOSPITALS
  1. KEY ANALYTICAL
    • 5 FORCES ANALYSIS
      • THREAT OF NEW ENTRANT
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • MERGER AND ACQUISITIONS
    • KEY BUYING CRITERIA
    • KEY TRENDS
      • DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
      • MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
      • INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
      • INCREASE IN NON-INVASIVE DEVICES
      • ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
    • REGULATION OF BLOOD SUGAR
    • INCIDENCE AND PREVALENCE OF DIABETES
  2. REGIONAL ANALYSIS
    • NORTH AMERICA
      • THE US
        • THE UNITED STATES HEALTH AND HEALTHCARE
        • THE UNITED STATES PHARMACEUTICAL MARKET
      • CANADA
        • CANADA HEALTH AND HEALTHCARE
        • CANADA PHARMACEUTICAL MARKET
        • CANADA DIABETES MARKET
  1. COMPETITIVE LANDSCAPE
    • MEDTRONIC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • DEXCOM
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • ABBOTT
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • JOHNSON AND JOHNSON
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • INSULET CORP
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • TANDEM DIABETES CARE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • ECHO THERAPEUTICS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • ROCHE DIAGNOSTICS
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • NEMAURA MEDICAL INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • SENSEONICS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • GLYSENS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • TERUMO
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • WOCKHARDT
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • I-SENS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • MORPEN LABORATORIES LTD.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • APEX BIOTECHNOLOGY CORP.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • ARKRAY INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC ANALYSIS
      • SCOT ANALYSIS
    • B BRAUN MELSUNGEN AG
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • ASCENSIA
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS

 

LIST OF TABLES  

TABLE 1       NORTH AMERICA CGMS MARKET, 2018-2026($ MILLION)

TABLE 2       NORTH AMERICA SMBG MARKET, 2018-2026 ($ MILLION)

TABLE 3       NORTH AMERICA CGMS MARKET, BY COMPONENT TYPE, 2018-2026($ MILLION)

TABLE 4       NORTH AMERICA CGMS SENSORS MARKET, 2018-2026 ($ MILLION)

TABLE 5       NORTH AMERICA CGMS TRANSMITTERS AND RECEIVERS MARKET,   2018-2026 ($ MILLION)

TABLE 6       NORTH AMERICA CGMS INSULIN PUMP MARKET, 2018-2026 ($ MILLION)

TABLE 7       NORTH AMERICA CGMS MARKET, BY APPLICATION 2018-2026 ($ MILLION)

TABLE 8       NORTH  AMERICA CGMS HOME SETTINGS MARKET, 2018-2026 ($ MILLION)

TABLE 9       NORTH AMERICA CGMS DIAGNOSTICS AND CLINICAL MARKET, 2018-2026 ($ MILLION)

TABLE 10     NORTH AMERICA CGMS HOSPITAL MARKET, 2018-2026 ($ MILLION)

TABLE 11     IMPORTANT ASPECTS FOR USE OF SMBG DEVICES IN HOME-CARE SETTINGS

TABLE 12     SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICAS

TABLE 13     PRODUCT MATRIX FOR LANCETS

TABLE 14     NORTH AMERICA SMBG MARKET, BY COMPONENT TYPE, 2018-2026 ($ MILLION)

TABLE 15     NORTH AMERICA SMBG LANCETS MARKET, 2018-2026 ($ MILLION)

TABLE 16     NORTH AMERICA SMBG HOME SETTING MARKET, 2018-2026 ($ MILLION)

TABLE 17     NORTH AMERICA SMBG CLINICAL MARKET, 2018-2026 ($ MILLION)

TABLE 18     NORTH AMERICA SMBG HOSPITALS MARKET, 2018-2026 ($ MILLION)

TABLE 19     NORTH AMERICA SMBG MARKET, 2018-2026 ($ MILLION)

TABLE 20     NORTH AMERICA SMBG MARKET 2018-2026 ($ MILLION)

TABLE 21     NORTH AMERICA CGMS MARKET 2018-2026 ($ MILLION)

 

LIST OF FIGURES

FIGURE 1     NORTH AMERICA CGMS SENSORS MARKET, 2018-2026($ MILLION)

FIGURE 2     NORTH AMERICA CGMS TRANSMITTERS AND RECEIVERS MARKET, 2018-2026($ MILLION)

FIGURE 3     NORTH AMERICA CGMS INSULIN PUMP MARKET, 2018-2026($ MILLION)

FIGURE 4     NORTH AMERICA CGMS SHARE, BY APPLICATION 2017 & 2026 (%)

FIGURE 5     NORTH AMERICA CGMS HOME SETTING MARKET, 2018-2026($ MILLION)

FIGURE 6     NORTH AMERICA CGMS DIAGNOSTICS AND CLINICAL MARKET, 2018-2026($ MILLION)

FIGURE 7     NORTH AMERICA CGMS HOSPITAL MARKET, 2018-2026($ MILLION)

FIGURE 8     NORTH AMERICA SMBG MARKET SHARE, BY COMPONENT TYPE 2017 & 2026(%)

FIGURE 9     NORTH AMERICA SMBG TEST STRIPS MARKET, 2018-2026 ($ MILLION)

FIGURE 10   NORTH AMERICA SMBG TEST STRIPS MARKET,  2018-2026 ($ MILLION)

FIGURE 11   NORTH AMERICA SMBG GLUCOSE METER MARKET, 2018-2026 ($ MILLION)

FIGURE 12   NORTH AMERICA SMBG GLUCOSE METER MARKET, 2018-2026 ($ MILLION)

FIGURE 13   NORTH AMERICA SMBG LANCETS MARKET, 2018-2026 ($ MILLION)

FIGURE 14   NORTH AMERICA SMBG MARKET SHARE, BY APPLICATION 2017& 2026(US $ MILLION)

FIGURE 15   NORTH AMERICA SMBG HOME SETTING MARKET, 2018-2026 ($ MILLION)

FIGURE 16   NORTH AMERICA SMBG CLINICAL MARKET, 2018-2026 ($ MILLION)

FIGURE 17   NORTH AMERICA SMBG HOSPITALS MARKET, 2018-2026 ($ MILLION)

FIGURE 18   NORTH AMERICA GGMS MARKET SHARE,  2017 & 2026 (%)

FIGURE 19   NORTH AMERICA CGMS MARKET SHARE, BY COUNTRY 2017 & 2026 (%)

FIGURE 20   US CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 21   US SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 22   CANADA CGMS MARKET REVENUE, 2018-2026 ($ MILLION)

FIGURE 23   CANADA SMBG MARKET REVENUE, 2018-2026 ($ MILLION)

  1. REGIONAL ANALYSIS
    • NORTH AMERICA
      • THE US
        • THE UNITED STATES HEALTH AND HEALTHCARE
        • THE UNITED STATES PHARMACEUTICAL MARKET
      • CANADA
        • CANADA HEALTH AND HEALTHCARE
        • CANADA PHARMACEUTICAL MARKET
        • CANADA DIABETES MARKET
  1. CGMS MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • SENSORS
      • TRANSMITTERS AND RECEIVERS
      • INSULIN PUMP
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • DIAGNOSTICS AND CLINICS
      • HOSPITALS
  1. SMBG MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • TEST STRIPS
      • GLUCOSE METER
      • LANCETS
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • CLINICS
      • HOSPITALS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now